MiniMed Introduces the MiniMed Flex™: A Revolutionary Insulin Pump for Easier Diabetes Management in Europe

MiniMed Introduces the MiniMed Flex™



In a significant advancement for diabetes management, MiniMed (Nasdaq: MMED), a key player in diabetes technology, has officially rolled out its newest product, the MiniMed Flex™, across Europe. This launch follows an initial phase where select customers experienced the device firsthand. The MiniMed Flex™ is not only the smallest automated insulin delivery (AID) system produced by the company but also the first that can be controlled via a mobile application, marking a major step forward in diabetes care.

Features of the MiniMed Flex™



The MiniMed Flex™ is designed with a sleek, screenless form factor, making it more user-friendly and discrete. This insulin pump is controlled through a compatible app available for both iOS and Android devices, allowing for seamless management without the cumbersome interactions typical of traditional insulin pumps. The system itself can hold up to 300 units of insulin, catering to various daily insulin needs. It is also compatible with the Extended™ infusion set, which is designed for wear up to seven days and results in significantly fewer injections compared to conventional methods.

What sets this insulin pump apart is its integration of the SmartGuard™ technology. The pump continuously adjusts insulin delivery based on real-time glucose readings, ensuring that users receive the right amount of insulin at all times. This feature is coupled with the innovative Meal Detection™ technology, which compensates when meal boluses are missed or carbohydrate intake is underestimated, enhancing the overall control of blood sugar levels.

User Experience



Slobodan Radumilo, Senior Vice President and Chief Commercial Officer for EMEA and APAC at MiniMed, emphasized the importance of technology that fits into users' daily lives. The MiniMed Flex™ aims to ease the burden of diabetes management without compromising clinical performance. Families appreciate that their loved ones are gaining more independence in their diabetes care, which is crucial for both children and adults alike.

For instance, Olof Wretling, a parent to a son who has lived with type 1 diabetes, shared that the MiniMed Flex™ allows his son to manage his condition more discreetly, reducing the need for parental oversight. This opinion is mirrored by healthcare professionals, such as Dr. Sharona Azriel from Madrid, who noted that adults with diabetes feel a significant shift in control when utilizing such an inconspicuous device.

Proven Technology in a Compact Design



The MiniMed Flex™ is underpinned by the same trusted SmartGuard™ algorithm found in the widely used MiniMed™ 780G system. Real-world data from studies with the 780G system show promising results, such as users achieving 80% time in range and significant overnight control of blood sugar levels, which can lead to improved sleep patterns.

The MiniMed Flex™ is approved for individuals aged two years and older with insulin-treated diabetes, including types 1 and 2. Its gradual rollout across European markets is accompanied by added compatibility with sensors, with the Simplera Sync™ sensor being the initial offering. This collaboration is expected to evolve further, with future compatible sensors enhancing the user experience.

Looking Ahead



As MiniMed pushes forward with innovations in diabetes care, the MiniMed Flex™ emerges as a testament to the company's commitment to improving the quality of life for those managing diabetes. By combining functionality with a modern, effective design, MiniMed has set a new standard in diabetes technology that aligns with the needs of today's users. As they continue to expand their reach and innovate further, the MiniMed Flex™ offers hope for easier and more effective diabetes management in everyday life.

With this innovative step, MiniMed aims to make a meaningful impact on diabetes management, making daily life less daunting for individuals and families coping with the challenges of this condition.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.